Novadaq Technologies Inc.TSX: NDQ

Ammended conference call notice

· Issued by Novadaq Technologies Inc. via CNW
Novadaq reschedules third quarter 2005 conference call and webcast

TORONTO, Nov. 4 /CNW/ - Novadaq(R) Technologies Inc. (TSX: NDQ) announces
it has rescheduled the Company's third quarter conference call to Thursday,
November 10, 2005 at 4:30 p.m. E.T. to discuss its financial results for the
quarter ended September 30, 2005. The Company also intends to change the
release date to disclose its financial results to November 10, 2005 before
market open.
To access the conference call by telephone, dial 1-800-814-4890 or     
416-644-3427. Please connect approximately ten minutes prior to the beginning
of the call to ensure participation. The conference call will be archived for
replay until November 17, 2005 at midnight. To access the archived conference
call, dial 416-640-1917 or 1-877-289-8525 enter the reservation number
21160122 followed by the number sign.
A live audio webcast of the conference call will be available at
www.novadaq.com. Please connect at least ten minutes prior to the conference
call to ensure adequate time for any software download that may be required to
join the webcast. The webcast will be archived at the above website for
90 days.

About Novadaq Technologies

Novadaq Technologies (TSX: NDQ) develops and commercializes medical
devices based on its proprietary imaging platform for the diagnosis and
treatment of human vascular and ophthalmic diseases and conditions. Novadaq's
SPY(R) Intra-operative Imaging System enables surgeons to visually assess
coronary vasculature and bypass graft functionality during the course of
cardiac surgery. Novadaq's ophthalmic product, the OPTTX(TM) System, is aimed
at the diagnosis, evaluation and treatment of wet Age-related Macular
Degeneration (AMD) by using the same core imaging technology that is used in
the SPY System. The OPTTX System is currently being evaluated in clinical
trials.
For more information, please visit the company's website at
www.novadaq.com.

Certain statements included in this press release may be considered
forward-looking. Such statements involve known and unknown risks,
uncertainties and other factors that may cause actual results, performance or
achievements to be materially different from those implied by such statements,
and therefore these statements should not be read as guarantees of future
performance or results. All forward-looking statements are based on Novadaq's
current beliefs as well as assumptions made by and information currently
available to Novadaq and relate to, among other things, anticipated financial
performance, business prospects, strategies, regulatory developments, market
acceptance and future commitments. Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as of the date
of this press release. Due to risks and uncertainties, including the risks and
uncertainties identified by Novadaq in its public securities filings, actual
events may differ materially from current expectations. Novadaq disclaims any
intention or obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.

%SEDAR: 00022069E

Novadaq Technologies Inc. on 6ix

Story so far

Earlier from Novadaq Technologies

Later from Novadaq Technologies

All Novadaq Technologies news releases